CHOLESTYRAMINE
NDC 68382-529, CHOLESTYRAMINE, powder, for suspension, from Zydus Pharmaceuticals (USA) Inc..
- Product NDC
- 68382-529
- Status
- Listed
- Labeler
- Zydus Pharmaceuticals (USA) Inc.
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA202902
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68382-529 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CHOLESTYRAMINE4 g/5.5g
Pharmacologic classes
Bile Acid Sequestrant [EPC]; Bile-acid Binding Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68382-529-42 | 68382052942 | 231 g in 1 CONTAINER (68382-529-42) |
| 68382-529-60 | 68382052960 | 60 POUCH in 1 CARTON (68382-529-60) / 5.5 g in 1 POUCH |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/2dcf7652-0c3e-4bc3-abfd-20a5b3d2a4f4NADAC price for package 68382052942
GET /v1/drugs/nadac/68382052942NADAC price for package 68382052960
GET /v1/drugs/nadac/68382052960
Use it
Look up 68382-529 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68382-529 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68382-529. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.